Discontinuation of Statins: What Are the Risks?

Volume: 18, Issue: 7
Published: May 25, 2016
Abstract
The key benefits of statin therapy have been well established in both primary and secondary prevention cardiovascular patients. Many studies have shown a significant statin discontinuation rate within the first year of initiation whether for primary or secondary prevention. National guidelines for the management of dyslipidemia highlight the lack of benefit seen with statin therapy in patients with chronic kidney disease receiving dialysis,...
Paper Details
Title
Discontinuation of Statins: What Are the Risks?
Published Date
May 25, 2016
Volume
18
Issue
7
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.